Insider Selling: PolyNovo Limited (ASX:PNV) Insider Sells 50,000 Shares of Stock

PolyNovo Limited (ASX:PNV) insider Andrew Lumsden sold 50,000 shares of the business’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of A$2.62 ($1.81), for a total transaction of A$130,900.00 ($90,275.86).

PolyNovo Stock Performance

The company has a debt-to-equity ratio of 21.32, a current ratio of 3.41 and a quick ratio of 1.58.

PolyNovo Company Profile

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.